Skip to content
GLP-1 Decoder

Semaglutide Side Effects by Frequency: Common, Serious

In the Ozempic label (semaglutide), nausea is the most common side effect: 20.3% on 1 mg vs 6.1% on placebo. Next come vomiting and diarrhea.

Most common
Nausea 20.3%
Same on placebo
6.1%
Trial group
Adults with type 2 diabetes

Wegovy in brief

How long it lasts in the body
100%50%25%0%07 d14 d21 d28 d35 d50%25%12.5%time after the dose

Its half-life is about 1 week. Once 7 d pass, half is gone, and about 3% stays after five half-lives (35 d).

How much weight was lost in its main trial
Wegovy (STEP 1)14.9%Placebo2.4%

In STEP 1, at 68 weeks: 14.9% of body weight, compared with 2.4% on placebo.

Cost as time goes on
202520262027$1,349.02$0List priceSelf-pay

Monthly prices in US dollars show the list price plus self-pay offers, each taken from the maker's price page.

Sources: FDA label (DailyMed), healthsystemtracker.org, prnewswire.com 1 2.

Semaglutide side effects: label rates vs placebo

You can buy Semaglutide under the names Ozempic, Wegovy and Rybelsus. Every label includes a separate table based on a different group.

Ozempic

Table 1. Adverse Reactions from Placebo-Controlled Trials Reported in ≥5% of OZEMPIC-Treated Patients who had Type 2 Diabetes Mellitus
Side effectPlaceboOzempic 0.5 mgOzempic 1 mgMore than placebo, 1 mg
Nausea6.1%15.8%20.3%+14.2 points
Vomiting2.3%5%9.2%+6.9 points
Diarrhea1.9%8.5%8.8%+6.9 points
Abdominal pain4.6%7.3%5.7%+1.1 points
Constipation1.5%5%3.1%+1.6 points

Source: FDA label (DailyMed).

Wegovy

Table 3. For WEGOVY 2.4 mg, Adverse Reactions in Injection-treated Adults with Obesity or Overweight for Weight Reduction Occurred in ≥2% and Were Greater Than Placebo
Side effectPlaceboWegovy 2.4 mgMore than placebo
Nausea16%44%+28 points
Diarrhea16%30%+14 points
Vomiting6%24%+18 points
Constipation11%24%+13 points
Abdominal Pain10%20%+10 points
Headache10%14%+4 points
Fatigue5%11%+6 points
Dyspepsia3%9%+6 points
Dizziness4%8%+4 points
Abdominal Distension5%7%+2 points
EructationNot reported7%–
Hypoglycemia in T2DM2%6%+4 points
Flatulence4%6%+2 points
Gastroenteritis4%6%+2 points
Gastroesophageal Reflux Disease3%5%+2 points
Gastritis1%4%+3 points
Gastroenteritis Viral3%4%+1 points
Hair Loss1%3%+2 points
Dysesthesia1%2%+1 points

Source: FDA label (DailyMed).

Rybelsus

Table 2. Placebo-Controlled Trials Reported Adverse Reactions in ≥5% of Semaglutide Tablets-Treated Patients who had Type 2 Diabetes Mellitus
Side effectPlaceboRybelsus 7 mgRybelsus 14 mgMore than placebo, 14 mg
Nausea6%11%20%+14 points
Abdominal Pain4%10%11%+7 points
Diarrhea4%9%10%+6 points
Decreased appetite1%6%9%+8 points
Vomiting3%6%8%+5 points
Constipation2%6%5%+3 points

Source: FDA label (DailyMed).

The serious warnings, explained simply

Source: FDA label (DailyMed).

Source: FDA label (DailyMed).

Each common side effect, listed separately

More questions people ask about semaglutide: Allergic reaction, Cancer risk, Butt changes, Headache, Heart effects, Dizziness, Dry mouth, Vision changes, Fatigue, Hair loss, Heartburn and indigestion, Muscle loss, Sulfur burps.